TGT Update, Fresh Options Idea

Target Corp. TGT

Just as we mentioned yesterday morning to start off the week, it was on Thursday morning that we signaled our interest in tracking some TGT Puts. They hadn’t quite heated up yet by the end of last week, but we urged readers yesterday to pay close attention, as the gains seemed imminent.

We were correct in that assumption, as the markets once again set a new record for worst daily losses in history. That helped propel the massive range of contracts we signaled, the TGT 04/03 $98-90 Puts, to double-bag gain status and beyond, exactly as we predicted.

Here are the trading ranges on those contracts since we’ve had them on our radar:

TGT 04/03 $98-90 Puts
$98: 3.37-6.92 (+105%)
$97: 2.90-6.60 (+128%)
$96: 2.73-6.00 (+120%)
$95: 2.21-5.95 (+169%)
$94: 2.54-5.50 (+117%)
$93: 1.99-5.05 (+154%)
$92: 2.44-4.50 (+84%)
$91: 2.00-4.25 (+113%)
$90: 1.47-3.80 (+156%)

Transdigm Group, Inc TDG

We would like to put together a set of call contracts to watch in the TDG chain. It’s no surprise that the stock is at a bottom at present, but what is remarkable is the amount of insider buying that has taken place in the last week, to the tune of roughly $180M.

That typically signals an insider’s confidence that the stock will not fall much further. We are going to put the TDG 05/15 $350-370 Calls on watch to track in the weeks ahead.

Extended Watchlist:

Expertly Timed Reversal

iBio, Inc. IBIO – Recap

Among those stocks that we have been tracking concurrently with the coronavirus outbreak in progress, is IBIO, which we just updated readers on in Friday morning’s report. We may be in line to see a better performance from stocks in general in contrast to last week’s historical market decline, which would lead to consolidation in stocks like IBIO, although it did manage to record an incredible new high Friday.

We had just recapped Thursday’s performance wherein the stock ran as high as .887, but Friday’s session took it to a whole new level. IBIO traded in a range from 1.50-3.40 for an intraday pop of 127%

Following our tag on Dec. 5th, the stock was trading for as little .189, and from there, Friday’s newly registered high represents an increase of 1699%

Innovation Pharmaceuticals, Inc. IPIX

We also want to watch IPIX, an OTCQB company which believes it has a scientific basis to believe that one of its preexisting treatments could be effective against coronavirus. We would suggest you read the PR outlining this in greater detail and keep IPIX on your radars. (>>View PR)


We also want to recap the performance of the SPY Calls we signaled on Friday morning, which will also continue to be in play for a potential market recovery this week.

We timed our flip-flop perfectly, having gone primarily with puts for our options ideas while the markets were in hysterics, and an intraday rebound provided for the following gain opportunities:

SPY 03/13 $298-301 Calls
$298: 5.67-9.41 (+66%)
$299: 5.44-8.45 (+55%)
$300: 4.65-9.32 (+100%)
$301: 4.54-9.00 (+98%)

Fresh Options Ideas:

JD Weekly $39.50-41.50 Calls

MTDR 04/17 $10-15 Calls
(Stock itself may be in play, extremely oversold)

Extended Watchlist:

New Highs to Report

More New Highs for Biotechs

Essentially every play we’ve been tracking that is in any way related to medical/biotech have been setting new highs as fast as we can update them. The coronavirus hysteria, along with an underlying need for a market correction is producing some incredible effects.  Here are the new highs on such stocks on our watchlist.

Co-Diagnostic Inc. CODX – As we were mentioning yesterday, we’ve been on the trail of CODX since the end of last month, at which time we observed a low of 1.52. Yesterday, just as we cautioned it would, the stock reached as high as 19.67. That extends our observed range on this play to 1194%

Vaxart Inc. VXRT – Another coronavirus play we’ve been watching has been VXRT, beginning on January 31st  at a low of .956, and there is an impressive new high to report here as well,. The stock hit 3.40 yesterday, which brings our total possible gains on VXRT to 256%

iBio, Inc. IBIO – Lastly, is a stock we placed on watch just a shade under three months ago, in IBIO. Subsequent to our tag on 12/05, we observed a low of .189 in IBIO, which has given way to a new high of .887 this week as viral virus fears continue to sweep the investment community. That represents a gain of 369%


Fresh Options Ideas: 
SPY 03/13 $298-301 Calls